che-20200428x8k

0000019584-20-000019.txt : 20200428 0000019584-20-000019.hdr.sgml : 20200428 20200428163051 ACCESSION NUMBER: 0000019584-20-000019 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200428 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMED CORP CENTRAL INDEX KEY: 0000019584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 310791746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08351 FILM NUMBER: 20825532 BUSINESS ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH ST CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: (513)762-6690 MAIL ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH STREET CITY: CINCINNATI STATE: OH ZIP: 45202-4726 FORMER COMPANY: FORMER CONFORMED NAME: ROTO-ROOTER INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: CHEMED CORP DATE OF NAME CHANGE: 19920703 8-K 1 che-20200428x8k.htm 8-K che-20200428x8k

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

April 28, 2020

CHEMED CORPORATION

(Exact name of registrant as specified in its charter)


Delaware	1-8351	31-0791746
(State or other ‎jurisdiction of ‎incorporation)	(Commission File Number)	(I.R.S. Employer ‎Identification ‎Number)

2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:

(513) 762-6690

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which

registered

Capital stock $1 par value

CHE

NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]

Page 1 of 3

Item 2.02 Results of Operations and Financial Condition

On April 28, 2020 Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2020. A copy of the release is furnished herewith as Exhibit 99.

Item 9.01 Financial Statements and Exhibits


d)	Exhibit

	(99) Registrant’s press release dated April 28, 2020
	104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL

Page 2 of 3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	CHEMED CORPORATION

Dated: April 28, 2020	By:	/s/ Michael D. Witzeman
		Michael D. Witzeman
		Vice President and Controller

Page 3 of 3

EX-99 2 che-20200428xex99.htm EX-99 Exhibit 99

CONTACT: David P. Williams

(513) 762-6901

Chemed Reports First-Quarter 2020 Results

CINCINNATI, April 28, 2020—Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2020, versus the comparable prior-year period, as follows:

Consolidated operating results:

Revenue increased 11.6% to $516 million

GAAP Diluted Earnings-per-Share (EPS) of $3.38, an increase of 25.2%

Adjusted Diluted EPS of $3.68, an increase of 26.0%

VITAS segment operating results:

Net Patient Revenue of $338 million, an increase of 10.1%

Average Daily Census (ADC) of 19,215, an increase of 4.7%

Admissions of 18,603, an increase of 4.8%

Net Income, excluding certain discrete items, of $42.5 million, an increase of 22.7%

Adjusted EBITDA, excluding Medicare Cap, of $60.2 million, an increase of 21.2%

Adjusted EBITDA margin, excluding Medicare Cap, of 17.7%, an increase of 167-basis points

Roto-Rooter segment operating results:

Revenue of $178 million, an increase of 14.6%

Net Income, excluding certain discrete items, of $26.7 million, an increase of 14.3%

Adjusted EBITDA of $40.0 million, an increase of 19.5%

Adjusted EBITDA margin of 22.5%, an increase of 92-basis points

VITAS

VITAS net revenue was $338 million in the first quarter of 2020, which is an increase of 10.1%, when compared to the prior-year period. This revenue increase is comprised primarily of a 5.9% increase in days-of-care, a geographically weighted average Medicare reimbursement rate increase of approximately 5.0%, and acuity mix shift which then reduced the Medicare rate increase

approximately 90-basis points. The combination of a decline in Medicare Cap, increase in Medicaid net room and board pass through and other contra revenue activity had minimal impact on overall revenue growth in the quarter.

In the first quarter of 2020, VITAS accrued $2.5 million in Medicare Cap billing limitations. This compares to the prior-year Medicare Cap billing limitation of $3.4 million.

VITAS currently has 30 Medicare provider numbers. During the first six months of the fiscal 2020 Medicare Cap year, 23 of these provider numbers have a Medicare Cap cushion of 10% or greater, two provider numbers have a cap cushion between 5% and 10%, two provider numbers have a cap cushion between 0% and 5%, and three provider numbers have an estimated 2020 Medicare Cap billing limitation.

Average revenue per patient per day in the first quarter of 2020 was $198.99, which, including acuity mix shift, is 4.1% above the prior-year period. Reimbursement for routine home care and high acuity care averaged $164.14 and $990.72, respectively. During the quarter, high acuity days-of-care were 4.2% of total days of care, 21-basis points less than the prior-year quarter. This 21-basis point mix shift in high acuity days-of-care reduced the increase in average revenue per patient per day from 5.0% to 4.1% in the quarter.

The first quarter 2020 gross margin, excluding Medicare Cap, was 23.8%, which is a 108-basis point margin improvement when compared to the first quarter of 2019.

Selling, general and administrative expense was $22.3 million in the first quarter of 2020, which is an increase of 3.4% compared to the prior-year quarter. Adjusted EBITDA, excluding Medicare Cap, totaled $60.2 million in the quarter, an increase of 21.2%. Adjusted EBITDA margin, excluding Medicare Cap, was 17.7% in the quarter, which is a 167-basis point improvement when compared to the prior-year period.

Roto-Rooter

Roto-Rooter generated quarterly revenue of $178 million for the first quarter of 2020, an increase of $22.6 million, or 14.6%, over the prior-year quarter. On a unit for unit basis, which excludes the Oakland and HSW acquisitions completed in July and September 2019, respectively, Roto-Rooter generated quarterly revenue of $158 million for the first quarter of 2020, an increase of 1.6%, over the prior-year quarter.

Including acquisitions, total commercial revenue increased 20.1%. This aggregate commercial revenue growth consisted of drain cleaning revenue expanding 25.0%, commercial plumbing and excavation increasing 20.1%, and commercial water restoration declining 4.4%.

Excluding acquisitions, commercial drain cleaning revenue were equal to the prior year, commercial plumbing and excavation declined 4.3%, and commercial water restoration declined 15.5%. Commercial water restoration represents approximately 10% of total water restoration service revenue. Overall, commercial revenue excluding acquisitions decreased 3.5%.

Including acquisitions, total residential revenue increased 11.7%. This aggregate residential revenue growth consisted of residential drain cleaning increasing 18.5%, plumbing and excavation expanding 14.4%, and residential water restoration increasing 1.0%.

Excluding acquisitions, residential drain cleaning increased 4.1%, plumbing and excavation increased 4.4%, and residential water restoration decreased 1.9%. Overall, residential sales excluding acquisitions increased 2.4%.

Roto-Rooter’s gross margin in the quarter was 48.1%, a 105-basis point increase when compared to the first quarter of 2019. Adjusted EBITDA in the first quarter of 2020 totaled $40.0 million, an increase of 19.5%. The Adjusted EBITDA margin in the quarter was 22.5% which is a 92-basis point increase when compared to the prior year.

Chemed Consolidated

As of March 31, 2020, Chemed had total cash and cash equivalents of $29.0 million and long-term debt of $160 million.

In June 2018, Chemed entered into a five-year Amended and Restated Credit Agreement that consists of a $450 million revolving credit facility. The interest rate on this facility has a floating rate that is currently LIBOR plus 100-basis points. At March 31, 2020, the Company had approximately $252 million of undrawn borrowing capacity under this credit agreement.

During the quarter, the Company repurchased 225,000 shares of Chemed stock for $100.2 million which equates to a cost per share of $445.49. On March 13, 2020, Chemed’s Board of Directors authorized an additional $250 million for stock repurchase under Chemed’s existing share repurchase program. As of March 31, 2020, there was approximately $254 million of remaining share repurchase authorization under this plan.

Chemed restarted its share repurchase program in 2007. Since that time Chemed has repurchased approximately 14.4 million shares, aggregating approximately $1.3 billion at an average share cost of $91.56. Including dividends over this period, Chemed has returned approximately $1.5 billion to shareholders.

Guidance for 2020

Management anticipates providing updated 2020 earnings guidance in July 2020 as part of the June 30, 2020, earnings press release.

Conference Call

Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, April 29, 2020, to discuss the Company's quarterly results and to provide an update on its business. The dial-in number for the conference call is (844) 743-2500 for U.S. and Canadian participants and

+1 (661) 378-9533 for international participants. The Conference ID is 2398574. A live webcast of the call can be accessed on Chemed's website at www.chemed.com by clicking on Investor Relations Home.

A taped replay of the conference call will be available beginning approximately 24 hours after the call's conclusion. It can be accessed by dialing (855) 859-2056 for U.S. and Canadian callers and +1 (404) 537-3406 for international callers and will be available for one week following the live call. The replay Conference ID is 2398574. An archived webcast will also be available at www.chemed.com.

Chemed Corporation operates in the healthcare field through its VITAS Healthcare Corporation subsidiary. VITAS provides daily hospice services to approximately 19,000 patients with severe, life-limiting illnesses. This type of care is focused on making the terminally ill patient's final days as comfortable and pain-free as possible.

Chemed operates in the residential and commercial plumbing and drain cleaning industry under the brand name Roto-Rooter. Roto-Rooter provides plumbing, drain cleaning, and water cleanup services through company-owned branches, independent contractors and franchisees in the United States and Canada. Roto-Rooter also has licensed master franchisees in the republics of Indonesia and Singapore, and the Philippines.

This press release contains information about Chemed’s EBITDA, Adjusted EBITDA and Adjusted Diluted EPS, which are not measures derived in accordance with GAAP and which exclude components that are important to understanding Chemed’s financial performance. In reporting its operating results, Chemed provides EBITDA, Adjusted EBITDA and Adjusted Diluted EPS measures to help investors and others evaluate the Company’s operating results, compare its operating performance with that of similar companies that have different capital structures and evaluate its ability to meet its future debt service, capital expenditures and working capital requirements. Chemed’s management similarly uses EBITDA, Adjusted EBITDA and Adjusted Diluted EPS to assist it in evaluating the performance of the Company across fiscal periods and in assessing how its performance compares to its peer companies. These measures also help Chemed’s management to estimate the resources required to meet Chemed’s future financial obligations and expenditures. Chemed’s EBITDA, Adjusted EBITDA and Adjusted Diluted EPS should not be considered in isolation or as a substitute for comparable measures calculated and presented in accordance with GAAP. We calculated Adjusted EBITDA Margin by dividing Adjusted EBITDA by service revenue and sales. A reconciliation of Chemed’s net income to its EBITDA, Adjusted EBITDA and Adjusted Diluted EPS is presented in the tables following the text of this press release.

Forward-Looking Statements

Certain statements contained in this press release and the accompanying tables are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "hope," "anticipate," "plan" and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Chemed does not undertake and specifically disclaims any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These statements are based on current expectations and assumptions and involve various risks and uncertainties, which could cause Chemed's actual results to differ from those expressed in such forward-looking statements.

These risks and uncertainties arise from, among other things, possible changes in regulations governing the hospice care or plumbing and drain cleaning industries; periodic changes in reimbursement levels and procedures under Medicare and Medicaid programs; difficulties predicting patient length of stay and estimating potential Medicare reimbursement obligations; challenges inherent in Chemed's growth strategy; the current shortage of qualified nurses, other healthcare professionals and licensed plumbing and drain cleaning technicians; Chemed’s dependence on patient referral sources; and other factors detailed under the caption "Description of Business by Segment" or "Risk Factors" in Chemed’s most recent report on form 10-Q or 10-K and its other filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on such forward-looking statements and there are no assurances that the matters contained in such statements will be achieved.


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)(unaudited)

	Three Months Ended March 31,
	2020		2019
Service revenues and sales	$	515,798	$	462,034
Cost of services provided and goods sold		351,745		321,951
Selling, general and administrative expenses (aa)		70,583		74,029
Depreciation		11,388		9,710
Amortization		2,477		519
Other operating expenses		242		6,353
Total costs and expenses		436,435		412,562
Income from operations		79,363		49,472
Interest expense		(975)		(1,124)
Other (expense)/income--net (bb)		(9,466)		2,439
Income before income taxes		68,922		50,787
Income taxes		(13,031)		(6,120)
Net income	$	55,891	$	44,667
Earnings Per Share
Net income	$	3.50	$	2.80
Average number of shares outstanding		15,991		15,954
Diluted Earnings Per Share
Net income	$	3.38	$	2.70
Average number of shares outstanding		16,516		16,525

(aa) Selling, general and administrative ("SG&A") expenses comprise (in thousands):

	Three Months Ended March 31,
	2020		2019
SG&A expenses before long-term incentive compensation
and the impact of market value adjustments related to
deferred compensation plans	$	78,334	$	70,203
Market value adjustments related to deferred
compensation trusts		(9,572)		2,338
Long-term incentive compensation		1,821		1,488
Total SG&A expenses	$	70,583	$	74,029

(bb) Other (expense)/income--net comprises (in thousands):
	Three Months Ended March 31,
	2020		2019
Market value adjustments related to deferred
compensation trusts	$	(9,572)	$	2,338
Interest income		106		101
Total other (expense)/income--net	$	(9,466)	$	2,439


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)(unaudited)

	March 31,
	2020		2019
Assets
Current assets
Cash and cash equivalents	$	28,951	$	8,768
Accounts receivable less allowances		134,695		119,575
Inventories		7,313		6,315
Prepaid income taxes		5,917		5,349
Prepaid expenses		21,939		19,148
Total current assets		198,815		159,155
Investments of deferred compensation plans held in trust		72,296		70,632
Properties and equipment, at cost less accumulated depreciation		183,729		164,629
Lease right of use asset		112,302		87,811
Identifiable intangible assets less accumulated amortization		124,219		67,868
Goodwill		577,236		510,598
Other assets		8,962		9,138
Total Assets	$	1,277,559	$	1,069,831
Liabilities
Current liabilities
Accounts payable	$	37,838	$	39,737
Income taxes		6,133		3,922
Accrued insurance		56,480		48,477
Accrued compensation		63,622		52,526
Accrued legal		7,114		8,163
Short-term lease liability		36,252		30,699
Other current liabilities		39,298		33,576
Total current liabilities		246,737		217,100
Deferred income taxes		20,681		18,108
Long-term debt		160,000		100,000
Deferred compensation liabilities		70,363		70,934
Long-term lease liability		88,278		67,960
Other liabilities		7,899		7,719
Total Liabilities		593,958		481,821
Stockholders' Equity
Capital stock		35,912		35,521
Paid-in capital		878,550		803,701
Retained earnings		1,476,151		1,265,485
Treasury stock, at cost		(1,709,390)		(1,519,077)
Deferred compensation payable in Company stock		2,378		2,380
Total Stockholders' Equity		683,601		588,010
Total Liabilities and Stockholders' Equity	$	1,277,559	$	1,069,831


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)(unaudited)

	For the Three Months Ended March 31,
	2020		2019
Cash Flows from Operating Activities
Net income	$	55,891	$	44,667
Adjustments to reconcile net income to net cash provided
by operating activities:
Depreciation and amortization		13,865		10,229
Stock option expense		5,045		4,089
Provision/(benefit) for deferred income taxes		2,290		(3,489)
Noncash long-term incentive compensation		1,598		1,119
Provision for bad debts		594		-
Amortization of debt issuance costs		76		76
Litigation settlement		-		6,000
Changes in operating assets and liabilities, excluding
amounts acquired in business combinations:
Decrease/(increase) in accounts receivable		6,269		(81)
Decrease/(increase) in inventories		149		(610)
Decrease in prepaid expenses		1,211		6
(Decrease)/increase in accounts payable and
other current liabilities		(7,037)		348
Change in current income taxes		10,159		9,219
Net change in lease assets and liabilities		(153)		(328)
Decrease/(increase) in other assets		5,048		(5,006)
(Decrease)/increase in other liabilities		(6,067)		6,459
Other sources		388		887
Net cash provided by operating activities		89,326		73,585
Cash Flows from Investing Activities
Capital expenditures		(19,897)		(13,866)
Business combinations		(1,452)		-
Other uses		(144)		(68)
Net cash used by investing activities		(21,493)		(13,934)
Cash Flows from Financing Activities
Proceeds from revolving line of credit		174,100		125,100
Payments on revolving line of credit		(104,100)		(114,300)
Purchases of treasury stock		(100,235)		(49,250)
Change in cash overdrafts payable		(9,849)		(13,303)
Proceeds from exercise of stock options		9,241		11,827
Capital stock surrendered to pay taxes on stock-based compensation		(7,951)		(11,170)
Dividends paid		(5,130)		(4,799)
Other (uses)/sources		(1,116)		181
Net cash used by financing activities		(45,040)		(55,714)
Increase in Cash and Cash Equivalents		22,793		3,937
Cash and cash equivalents at beginning of year		6,158		4,831
Cash and cash equivalents at end of year	$	28,951	$	8,768


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATING STATEMENTS OF INCOME
FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019
(in thousands)(unaudited)
							Chemed
	VITAS		Roto-Rooter		Corporate		Consolidated
2020 (a)
Service revenues and sales	$	337,916	$	177,882	$	-	$	515,798
Cost of services provided and goods sold		259,429		92,316		-		351,745
Selling, general and administrative expenses		22,269		46,282		2,032		70,583
Depreciation		5,474		5,878		36		11,388
Amortization		18		2,459		-		2,477
Other operating expense		114		128		-		242
Total costs and expenses		287,304		147,063		2,068		436,435
Income/(loss) from operations		50,612		30,819		(2,068)		79,363
Interest expense		(45)		(102)		(828)		(975)
Intercompany interest income/(expense)		4,386		1,349		(5,735)		-
Other (expense)/income—net		65		40		(9,571)		(9,466)
Income/(loss) before income taxes		55,018		32,106		(18,202)		68,922
Income taxes		(13,739)		(7,784)		8,492		(13,031)
Net income/(loss)	$	41,279	$	24,322	$	(9,710)	$	55,891

2019 (b)
Service revenues and sales	$	306,781	$	155,253	$	-	$	462,034
Cost of services provided and goods sold		239,743		82,208		-		321,951
Selling, general and administrative expenses		21,536		39,601		12,892		74,029
Depreciation		4,708		4,963		39		9,710
Amortization		18		501		-		519
Other operating expense		6,354		(1)		-		6,353
Total costs and expenses		272,359		127,272		12,931		412,562
Income/(loss) from operations		34,422		27,981		(12,931)		49,472
Interest expense		(47)		(95)		(982)		(1,124)
Intercompany interest income/(expense)		4,394		2,195		(6,589)		-
Other income—net		88		14		2,337		2,439
Income/(loss) before income taxes		38,857		30,095		(18,165)		50,787
Income taxes (b)		(9,569)		(7,109)		10,558		(6,120)
Net income/(loss)	$	29,288	$	22,986	$	(7,607)	$	44,667


The "Footnotes to Financial Statements" are integral parts of this financial information.


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATING SUMMARIES OF EBITDA
FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019
(in thousands)(unaudited)
							Chemed
	VITAS		Roto-Rooter		Corporate		Consolidated
2020
Net income/(loss)	$	41,279	$	24,322	$	(9,710)	$	55,891
Add/(deduct):
Interest expense		45		102		828		975
Income taxes		13,739		7,784		(8,492)		13,031
Depreciation		5,474		5,878		36		11,388
Amortization		18		2,459		-		2,477
EBITDA		60,555		40,545		(17,338)		83,762
Add/(deduct):
Intercompany interest expense/(income)		(4,386)		(1,349)		5,735		-
Interest income		(68)		(40)		-		(108)
Stock option expense		-		-		5,045		5,045
Direct costs related to COVID-19		973		861		-		1,834
Long-term incentive compensation		-		-		1,821		1,821
Medicare cap sequestration adjustment		675		-		-		675
Adjusted EBITDA	$	57,749	$	40,017	$	(4,737)	$	93,029

2019
Net income/(loss)	$	29,288	$	22,986	$	(7,607)	$	44,667
Add/(deduct):
Interest expense		47		95		982		1,124
Income taxes		9,569		7,109		(10,558)		6,120
Depreciation		4,708		4,963		39		9,710
Amortization		18		501		-		519
EBITDA		43,630		35,654		(17,144)		62,140
Add/(deduct):
Intercompany interest expense/(income)		(4,394)		(2,195)		6,589		-
Interest income		(88)		(14)		-		(102)
Litigation settlement		6,000		-		-		6,000
Non cash ASC 842 expenses/(benefit)		656		55		(163)		548
Medicare cap sequestration adjustment		515		-		-		515
Acquisition expense		-		-		120		120
Stock option expense		-		-		4,089		4,089
Long-term incentive compensation		-		-		1,488		1,488
Adjusted EBITDA	$	46,319	$	33,500	$	(5,021)	$	74,798

The "Footnotes to Financial Statements" are integral parts of this financial information.


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
RECONCILIATION OF ADJUSTED NET INCOME
(in thousands, except per share data)(unaudited)

	Three Months Ended March 31,
	2020		2019
Net income as reported	$	55,891	$	44,667
Add/(deduct) pre-tax cost of:
Stock option expense		5,045		4,089
Amortization of reacquired franchise agreements		2,352		441
Direct costs related to COVID-19		1,834		-
Long-term incentive compensation		1,821		1,488
Medicare cap sequestration adjustments		675		515
Litigation settlement		-		6,000
Acquisition expense		-		120
Non cash ASC 842 expenses		-		548
Add/(deduct) tax impacts:
Tax impact of the above pre-tax adjustments (1)		(2,350)		(2,961)
Excess tax benefits on stock compensation		(4,553)		(6,732)
Adjusted net income	$	60,715	$	48,175

Diluted Earnings Per Share As Reported
Net income	$	3.38	$	2.70
Average number of shares outstanding		16,516		16,525

Adjusted Diluted Earnings Per Share
Adjusted net income	$	3.68	$	2.92
Average number of shares outstanding		16,516		16,525

(1) The tax impact of pre-tax adjustments was calculated using the effective tax rate of the operating unit for which each adjustment is associated.

The "Footnotes to Financial Statements" are integral parts of this financial information.


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
OPERATING STATISTICS FOR VITAS SEGMENT (unaudited)
	Three Months Ended March 31,
OPERATING STATISTICS	2020			2019
Net revenue ($000) (c)
Homecare	$	271,762		$	258,847
Inpatient		32,482			22,570
Continuous care		40,555			32,244
Other		3,147			2,010
Subtotal	$	347,946		$	315,671
Room and board, net		(3,381)			(2,542)
Contractual allowances		(4,149)			(2,948)
Medicare cap allowance		(2,500)			(3,400)
Net Revenue	$	337,916		$	306,781
Net revenue as a percent of total before Medicare cap allowance
Homecare		78.1	%		82.0	%
Inpatient		9.3			7.1
Continuous care		11.7			10.2
Other		0.9			0.7
Subtotal		100.0			100.0
Room and board, net		(1.0)			(0.9)
Contractual allowances		(1.2)			(1.0)
Medicare cap allowance		(0.7)			(0.9)
Net Revenue		97.1	%		97.2	%
Days of care
Homecare		1,364,746			1,281,899
Nursing home		303,374			289,769
Respite		6,692			6,301
Subtotal routine homecare and respite		1,674,812			1,577,969
Inpatient		32,348			29,150
Continuous care		41,373			43,923
Total		1,748,533			1,651,042
Number of days in relevant time period		91			90
Average daily census ("ADC") (days)
Homecare		14,997			14,243
Nursing home		3,334			3,220
Respite		74			70
Subtotal routine homecare and respite		18,405			17,533
Inpatient		355			324
Continuous care		455			488
Total		19,215			18,345
Total Admissions		18,603			17,758
Total Discharges		18,196			17,339
Average length of stay (days)		90.7			91.3
Median length of stay (days)		14.0			15.0
ADC by major diagnosis
Cerebro		35.9	%		35.6	%
Neurological		21.4			19.9
Cancer		12.7			13.1
Cardio		15.9			16.9
Respiratory		8.3			8.2
Other		5.8			6.3
Total		100.0	%		100.0	%
Admissions by major diagnosis
Cerebro		21.1	%		20.7	%
Neurological		12.5			12.8
Cancer		28.3			28.0
Cardio		15.1			16.3
Respiratory		12.2			12.0
Other		10.8			10.2
Total		100.0	%		100.0	%
Estimated uncollectible accounts as a percent of revenues		1.2	%		1.0	%
Accounts receivable --
Days of revenue outstanding- excluding unapplied Medicare payments		33.9			34.9
Days of revenue outstanding- including unapplied Medicare payments		26.1			23.3
The "Footnotes to Financial Statements" are integral parts of this financial information.


CHEMED CORPORATION AND SUBSIDIARY COMPANIES
FOOTNOTES TO FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019
(unaudited)

(a)	Included in the results of operations for 2020 are the following significant credits/(charges) which may not be indicative of ongoing operations
	(in thousands):
		Three Months Ended March 31, 2020
		VITAS		Roto-Rooter		Corporate		Consolidated

	Stock option expense	$	-	$	-	$	(5,045)	$	(5,045)
	Amortization of reacquired franchise agreements		-		(2,352)		-		(2,352)
	Direct costs related to COVID-19		(973)		(861)		-		(1,834)
	Long-term incentive compensation		-		-		(1,821)		(1,821)
	Medicare cap sequestration adjustment		(675)		-		-		(675)
	Pretax impact on earnings		(1,648)		(3,213)		(6,866)		(11,727)
	Excess tax benefits on stock compensation		-		-		4,553		4,553
	Income tax benefit on the above		419		851		1,080		2,350
	After-tax impact on earnings	$	(1,229)	$	(2,362)	$	(1,233)	$	(4,824)


(b)	Included in the results of operations for 2019 are the following significant credits/(charges) which may not be indicative of ongoing operations
	(in thousands):
		Three Months Ended March 31, 2019
		VITAS		Roto-Rooter		Corporate		Consolidated

	Litigation settlement	$	(6,000)	$	-	$	-	$	(6,000)
	Stock option expense		-		-		(4,089)		(4,089)
	Long-term incentive compensation		-		-		(1,488)		(1,488)
	Non cash ASC 842 (expenses)/benefit		(656)		(55)		163		(548)
	Medicare cap sequestration adjustment		(515)		-		-		(515)
	Amortization of reacquired franchise agreements		-		(441)		-		(441)
	Acquisition expense		-		-		(120)		(120)
	Pretax impact on earnings		(7,171)		(496)		(5,534)		(13,201)
	Excess tax benefits on stock compensation		-		-		6,732		6,732
	Income tax benefit on the above		1,819		132		1,010		2,961
	After-tax impact on earnings	$	(5,352)	$	(364)	$	2,208	$	(3,508)


(c)	VITAS has 11 large (greater than 450 ADC), 22 medium (greater than 200 but less than 450 ADC) and 15 small (less than 200 ADC) hospice programs. Of Vitas' 30 Medicare provider numbers, for the first six months of the current cap year, 23 provider numbers have a Medicare cap cushion of 10% or greater, two provider numbers have a cap cushion between 5% and 10%, two provider numbers have a cap cushion between 0% and 5%, and three provider numbers have a Medicare cap liability.

GRAPHIC 3 che-20200428xex99g001.jpg GRAPHIC begin 644 che-20200428xex99g001.jpg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end EX-101.SCH 4 che-20200428.xsd EX-101.SCH 00090 - Document - Document And Entity Informationlink:presentationLinklink:calculationLinklink:definitionLink EX-101.LAB 5 che-20200428_lab.xml EX-101.LAB Document And Entity Information [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Class of Stock [Line Items] Class of Stock [Line Items] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity File Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag EX-101.PRE 6 che-20200428_pre.xml EX-101.PRE XML 8 che-20200428x8k_htm.xml IDEA: XBRL DOCUMENT 0000019584 2020-04-28 2020-04-28 false 0000019584 8-K 2020-04-28 CHEMED CORPORATION DE 1-8351 31-0791746 2600 First Financial Center, 255 East 5th Street Cincinnati OH 45202 513 762-6690 false false false false Capital stock $1 par value CHE NYSE false ZIP 9 0000019584-20-000019-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000019584-20-000019-xbrl.zip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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.1

Document And Entity Information

Apr. 28, 2020

Document And Entity Information [Abstract]

Document Type 8-K

Document Period End Date Apr. 28, 2020

Entity Registrant Name CHEMED CORPORATION

Entity Incorporation, State or Country Code DE

Entity File Number 1-8351

Entity Tax Identification Number 31-0791746

Entity Address, Address Line One 2600 First Financial Center, 255 East 5th Street

Entity Address, City or Town Cincinnati

Entity Address, State or Province OH

Entity Address, Postal Zip Code 45202

City Area Code 513

Local Phone Number 762-6690

Written Communications false

Soliciting Material false

Pre Commencement Tender Offer false

Pre Commencement Issuer Tender Offer false

Title of 12(b) Security Capital stock $1 par value

Trading Symbol CHE

Security Exchange Name NYSE

Entity Emerging Growth Company false

Entity Central Index Key 0000019584

Amendment Flag false

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cover page.
+ References
No definition available.
+ Details

Name: dei_CoverAbstract

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the state or province.
+ References
No definition available.
+ Details

Name: dei_EntityAddressStateOrProvince

Namespace Prefix: dei_

Data Type: dei:stateOrProvinceItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details

Name: dei_PreCommencementIssuerTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details

Name: dei_PreCommencementTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
+ Details

Name: dei_SolicitingMaterial

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details

Name: dei_WrittenCommunications

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.sec.gov/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports che-20200428x8k.htm che-20200428.xsd che-20200428_lab.xml che-20200428_pre.xml che-20200428xex99.htm http://xbrl.sec.gov/dei/2019-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "che-20200428x8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "che-20200428x8k.htm" ] }, "labelLink": { "local": [ "che-20200428_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "che-20200428_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "che-20200428.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "che-20200428x8k.htm", "contextRef": "Duration_4_28_2020_To_4_28_2020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document And Entity Information", "role": "http://www.sec.gov/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "che-20200428x8k.htm", "contextRef": "Duration_4_28_2020_To_4_28_2020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Document And Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sec.gov/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }

Document And Entity Information	Apr. 28, 2020
Document And Entity Information [Abstract]
Document Type	8-K
Document Period End Date	Apr. 28, 2020
Entity Registrant Name	CHEMED CORPORATION
Entity Incorporation, State or Country Code	DE
Entity File Number	1-8351
Entity Tax Identification Number	31-0791746
Entity Address, Address Line One	2600 First Financial Center, 255 East 5th Street
Entity Address, City or Town	Cincinnati
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45202
City Area Code	513
Local Phone Number	762-6690
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Title of 12(b) Security	Capital stock $1 par value
Trading Symbol	CHE
Security Exchange Name	NYSE
Entity Emerging Growth Company	false
Entity Central Index Key	0000019584
Amendment Flag	false